Literature DB >> 24093465

Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management.

Magdalena Doktorova, Zuzana Motovska.   

Abstract

This article focuses on the incidence, predictors, classification, impact on prognosis, and management of bleeding associated with the treatment of acute coronary syndrome. The issue of bleeding complications is related to the continual improvement of ischemic heart disease treatment, which involves mainly (a) the widespread use of coronary angiography, (b) developments in percutaneous coronary interventions, and (c) the introduction of new antithrombotics. Bleeding has become an important health and economic problem and has an incidence of 2.0% to 17%. Bleeding significantly influences both the short- and long-term prognoses. If a group of patients at higher risk of bleeding complications can be identified according to known risk factors and a risk scoring system can be developed, we may focus more on preventive measures that should help us to reduce the incidence of bleeding.

Entities:  

Mesh:

Year:  2013        PMID: 24093465      PMCID: PMC4056027          DOI: 10.1186/cc12764

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  72 in total

Review 1.  Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention.

Authors:  Dominique Joyal; Olivier F Bertrand; Stéphane Rinfret; Avi Shimony; Mark J Eisenberg
Journal:  Am J Cardiol       Date:  2011-12-22       Impact factor: 2.778

Review 2.  Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.

Authors:  Sandeep Nathan; Sunil V Rao
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

3.  Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.

Authors:  Dale R Tavris; Yongfei Wang; Samantha Jacobs; Beverly Gallauresi; Jeptha Curtis; John Messenger; Frederic S Resnic; Susan Fitzgerald
Journal:  J Invasive Cardiol       Date:  2012-07       Impact factor: 2.022

4.  A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices.

Authors:  Nipun Arora; Michael E Matheny; Carrie Sepke; Frederic S Resnic
Journal:  Am Heart J       Date:  2007-04       Impact factor: 4.749

5.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

Review 6.  A transition of P2Y12 antagonists for acute coronary syndrome: benefits, risks and costs.

Authors:  Wei Eric Wang; Hongyong Wang; Xukai Wang; Chunyu Zeng
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

7.  Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

Authors:  Payal Kohli; Lars Wallentin; Eric Reyes; Jay Horrow; Steen Husted; Dominick J Angiolillo; Diego Ardissino; Gerald Maurer; Joao Morais; José C Nicolau; Ali Oto; Robert F Storey; Stefan K James; Christopher P Cannon
Journal:  Circulation       Date:  2012-12-31       Impact factor: 29.690

8.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

9.  Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997.

Authors:  Michael A Lauer; Jennifer A Karweit; Elisa F Cascade; Nancy D Lin; Eric J Topol
Journal:  Am J Cardiol       Date:  2002-04-15       Impact factor: 2.778

10.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

Authors:  Timothy D Kinnaird; Eugenio Stabile; Gary S Mintz; Cheol Whan Lee; Daniel A Canos; Natalie Gevorkian; Ellen E Pinnow; Kenneth M Kent; Augusto D Pichard; Lowell F Satler; Neil J Weissman; Joseph Lindsay; Shmuel Fuchs
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

View more
  3 in total

Review 1.  Factor IX(a) inhibitors: an updated patent review (2003-present).

Authors:  Daniel K Afosah; Edward Ofori; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  Expert Opin Ther Pat       Date:  2022-01-17       Impact factor: 6.674

2.  Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort.

Authors:  Maria Wanitschek; Michael Edlinger; Jakob Dörler; Hannes F Alber
Journal:  BMJ Open       Date:  2018-06-06       Impact factor: 2.692

Review 3.  Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities.

Authors:  Tristram A J Ryan; Luke A J O'Neill
Journal:  Eur J Immunol       Date:  2022-05-24       Impact factor: 6.688

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.